Iconovo - Asset Resilience Ratio
Iconovo (ICO) has an Asset Resilience Ratio of 3.83% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ICO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Iconovo's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Iconovo's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Iconovo's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read ICO total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr6.21 Million | 3.83% |
| Total Liquid Assets | Skr6.21 Million | 3.83% |
Asset Resilience Insights
- Limited Liquidity: Iconovo maintains only 3.83% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Iconovo Industry Peers by Asset Resilience Ratio
Compare Iconovo's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Iconovo (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Iconovo.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 3.76% | Skr4.93 Million ≈ $530.44K |
Skr131.08 Million ≈ $14.11 Million |
+0.28pp |
| 2024-12-31 | 3.48% | Skr5.07 Million ≈ $545.51K |
Skr145.69 Million ≈ $15.68 Million |
-14.75pp |
| 2023-12-31 | 18.22% | Skr23.34 Million ≈ $2.51 Million |
Skr128.08 Million ≈ $13.78 Million |
+7.14pp |
| 2022-12-31 | 11.09% | Skr13.45 Million ≈ $1.45 Million |
Skr121.27 Million ≈ $13.05 Million |
-52.82pp |
| 2021-12-31 | 63.91% | Skr94.94 Million ≈ $10.22 Million |
Skr148.54 Million ≈ $15.99 Million |
+2.86pp |
| 2020-12-31 | 61.05% | Skr61.69 Million ≈ $6.64 Million |
Skr101.04 Million ≈ $10.87 Million |
-17.33pp |
| 2019-12-31 | 78.38% | Skr89.16 Million ≈ $9.59 Million |
Skr113.75 Million ≈ $12.24 Million |
+5.41pp |
| 2018-12-31 | 72.97% | Skr53.05 Million ≈ $5.71 Million |
Skr72.70 Million ≈ $7.82 Million |
+19.58pp |
| 2017-12-31 | 53.39% | Skr22.48 Million ≈ $2.42 Million |
Skr42.10 Million ≈ $4.53 Million |
-3.99pp |
| 2016-12-31 | 57.39% | Skr11.54 Million ≈ $1.24 Million |
Skr20.11 Million ≈ $2.16 Million |
-- |
About Iconovo
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more